• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中肠道微生物群的分子分析。

Molecular analysis of the intestinal microflora in IBD.

作者信息

Tannock G W

机构信息

Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.

出版信息

Mucosal Immunol. 2008 Nov;1 Suppl 1:S15-8. doi: 10.1038/mi.2008.54.

DOI:10.1038/mi.2008.54
PMID:19079221
Abstract

Nucleic acid-based (molecular) analytical methods have utility in discriminating between bowel microbiota of altered compositions. This has been demonstrated in studies involving both experimental animals and humans with inflammation of the bowel. Although alterations in the composition of the microbiota can be demonstrated, future studies need to provide functional links between the candidate proinflammatory agents and disease processes.

摘要

基于核酸的(分子)分析方法在鉴别组成改变的肠道微生物群方面具有实用性。这一点已在涉及实验动物和患有肠道炎症的人类的研究中得到证实。虽然微生物群的组成变化可以得到证明,但未来的研究需要提供候选促炎因子与疾病过程之间的功能联系。

相似文献

1
Molecular analysis of the intestinal microflora in IBD.炎症性肠病中肠道微生物群的分子分析。
Mucosal Immunol. 2008 Nov;1 Suppl 1:S15-8. doi: 10.1038/mi.2008.54.
2
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.患有炎症性肠病的儿科患者的肠道相关细菌微生物群。
Gut. 2006 Dec;55(12):1760-7. doi: 10.1136/gut.2005.078824. Epub 2006 Apr 28.
3
Practical Considerations and the Intestinal Microbiome in Disease: Antibiotics for IBD Therapy.疾病中的实际考量与肠道微生物群:用于炎症性肠病治疗的抗生素
Dig Dis. 2016;34(1-2):112-21. doi: 10.1159/000443014. Epub 2016 Mar 16.
4
Review--antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach.综述——炎症性肠病的抗生素治疗:利福昔明,一种新的可能方法。
Eur Rev Med Pharmacol Sci. 1999 Jan-Feb;3(1):27-30.
5
Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.肠道微生物群与炎症性肠病:抗生素在疾病管理中的作用。
Postgrad Med. 2014 Jul;126(4):7-19. doi: 10.3810/pgm.2014.07.2779.
6
The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.炎症性肠病中的细菌菌群:发病机制的当前见解以及抗生素和益生菌的影响
Scand J Gastroenterol Suppl. 2001(234):29-40. doi: 10.1080/003655201753265082.
7
Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease.肠道炎症调节炎症性肠病患者对丁酸盐的上皮反应。
Inflamm Bowel Dis. 2020 Jan 1;26(1):43-55. doi: 10.1093/ibd/izz119.
8
Fungi and inflammatory bowel diseases: Alterations of composition and diversity.真菌与炎症性肠病:组成与多样性的改变
Scand J Gastroenterol. 2008;43(7):831-41. doi: 10.1080/00365520801935434.
9
Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis.硫酸盐还原菌定殖于溃疡性结肠炎形成的袋囊中,而非家族性腺瘤性息肉病形成的袋囊中。
Dis Colon Rectum. 2002 Mar;45(3):384-8. doi: 10.1007/s10350-004-6187-z.
10
Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.炎症性肠病患者幽门螺杆菌感染率的评估。
Eur J Gastroenterol Hepatol. 2000 Apr;12(4):439-43. doi: 10.1097/00042737-200012040-00012.

引用本文的文献

1
Carotenoid productivity in human intestinal bacteria and with functional analysis of their carotenoid biosynthesis genes.人类肠道细菌中的类胡萝卜素生产力及其类胡萝卜素生物合成基因的功能分析。
Eng Microbiol. 2024 Mar 28;4(2):100147. doi: 10.1016/j.engmic.2024.100147. eCollection 2024 Jun.
2
Gut Barrier Damage and Gut Translocation of Pathogen Molecules in Lupus, an Impact of Innate Immunity (Macrophages and Neutrophils) in Autoimmune Disease.狼疮中的肠道屏障损伤和病原体分子的肠道易位,固有免疫(巨噬细胞和中性粒细胞)在自身免疫性疾病中的作用。
Int J Mol Sci. 2022 Jul 26;23(15):8223. doi: 10.3390/ijms23158223.
3
Effect of the standard herbal preparation, STW5, treatment on dysbiosis induced by dextran sodium sulfate in experimental colitis.
STW5 标准草药制剂治疗葡聚糖硫酸钠诱导实验性结肠炎的菌群失调。
BMC Complement Med Ther. 2021 Jun 8;21(1):168. doi: 10.1186/s12906-021-03337-8.
4
Isoxanthohumol, a hop-derived flavonoid, alters the metabolomics profile of mouse feces.异黄腐醇,一种来自啤酒花的类黄酮,可改变小鼠粪便的代谢组学特征。
Biosci Microbiota Food Health. 2020;39(3):100-108. doi: 10.12938/bmfh.2019-045. Epub 2020 Feb 21.
5
Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response.炎症性肠病类型在炎症标志物、肠道屏障和特定的抗细菌反应方面存在差异。
Cells. 2019 Jul 13;8(7):719. doi: 10.3390/cells8070719.
6
Effect of Dahuang Danpi Decoction on Lactobacillus bulgaricus growth and metabolism: In vitro study.大黄丹皮汤对保加利亚乳杆菌生长和代谢的影响:体外研究
Medicine (Baltimore). 2019 Feb;98(5):e13941. doi: 10.1097/MD.0000000000013941.
7
Intestinal bacteria detected in cancer and adjacent tissue from patients with colorectal cancer.在结直肠癌患者的癌组织及相邻组织中检测到的肠道细菌。
Oncol Lett. 2019 Jan;17(1):1115-1127. doi: 10.3892/ol.2018.9714. Epub 2018 Nov 15.
8
Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.评估 Toll 样受体 (TLRs) 在结直肠癌患者癌症发展和进展中的检测。
PLoS One. 2018 Jun 8;13(6):e0197327. doi: 10.1371/journal.pone.0197327. eCollection 2018.
9
Microbial Ecology along the Gastrointestinal Tract.胃肠道中的微生物生态学
Microbes Environ. 2017 Dec 27;32(4):300-313. doi: 10.1264/jsme2.ME17017. Epub 2017 Nov 10.
10
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.原发性硬化性胆管炎和溃疡性结肠炎患者不同的肠道微生物群特征。
World J Gastroenterol. 2017 Jul 7;23(25):4548-4558. doi: 10.3748/wjg.v23.i25.4548.